ERBB2 and breast cancer: Most importantly, PLAU was highly expressed in triple-negative breast cancer (TNBC) (Fig. 2A), a subtype of basal-like breast cancer that does not express ER, PR, and HER2, with high invasiveness and high metastatic potential (24).